| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |